Volume 14 (2016): Issue 9 (Sep 2016)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xvii–xxii
Oncology Research Program
Pages: xxiv
Hillary and Donald, Our Patients Are Watching
By: Margaret Tempero
Pages: 1047
Allogeneic Hematopoietic Cell Transplantation for AML—A Missed Opportunity!
By: Margaret R. O'Donnell
Pages: 1052–1053
Characterization of Prostate Cancer in a Functional Eunuch
By: John J. Stocking, Michael V. Fiandalo, Elena A. Pop, John H. Wilton, Gissou Azabdaftari, and James L. Mohler
Pages: 1054–1060
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016
By: Steven M. Horwitz, Andrew D. Zelenetz, Leo I. Gordon, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, John C. Byrd, Luis E. Fayad, Richard I. Fisher, Martha J. Glenn, Thomas M. Habermann, Nancy Lee Harris, Francisco Hernandez-Ilizaliturri, Richard T. Hoppe, Mark S. Kaminski, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Matthew Lunning, Auayporn Nademanee, Oliver Press, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Kenneth Roberts, Ayman A. Saad, Lubomir Sokol, Lode J. Swinnen, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Mary Dwyer, Hema Sundar, and Pierluigi Porcu
Pages: 1067–1079
Predictors of Antiestrogen Recommendation in Women With Estrogen Receptor–Positive Ductal Carcinoma In Situ
By: Rondi M. Kauffmann, Leanne Goldstein, Emily Marcinkowski, George Somlo, Yuan Yuan, Philip H.G. Ituarte, Laura Kruper, Leslie Taylor, and Courtney Vito
Pages: 1081–1090
Current Status of Distress Screening in Designated Cancer Hospitals: A Cross-Sectional Nationwide Survey in Japan
By: Toru Okuyama, Yoshiyuki Kizawa, Tatsuya Morita, Hiroya Kinoshita, Megumi Uchida, Asami Shimada, Akemi Shirado Naito, and Tatsuo Akechi
Pages: 1098–1104
The Population Benefit of Radiotherapy for Malignant Brain Tumors: Local Control and Survival Estimates for Guideline-Based Use
By: Timothy Paul Hanna, Geoffrey Paul Delaney, and Michael Bernard Barton
Pages: 1111–1119
Risk Factors for Early Death After Rituximab-Based Immunochemotherapy in Older Patients With Diffuse Large B-Cell Lymphoma
By: Adam J. Olszewski, Kalyan C. Mantripragada, and Jorge J. Castillo
Pages: 1121–1129
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
By: Robert J. Morgan Jr, Deborah K. Armstrong, Ronald D. Alvarez, Jamie N. Bakkum-Gamez, Kian Behbakht, Lee-may Chen, Larry Copeland, Marta Ann Crispens, Maria DeRosa, Oliver Dorigo, David M. Gershenson, Heidi J. Gray, Ardeshir Hakam, Laura J. Havrilesky, Carolyn Johnston, Shashikant Lele, Lainie Martin, Ursula A. Matulonis, David M. O'Malley, Richard T. Penson, Sanja Percac-Lima, Mario Pineda, Steven C. Plaxe, Matthew A. Powell, Elena Ratner, Steven W. Remmenga, Peter G. Rose, Paul Sabbatini, Joseph T. Santoso, Theresa L. Werner, Jennifer Burns, and Miranda Hughes
Pages: 1134–1163
Next-Generation Sequencing: Role in Gynecologic Cancers
By: Tarra Evans and Ursula Matulonis
Pages: 1165–1173
Principles of Treatment for Borderline, Micropapillary Serous, and Low-Grade Ovarian Cancer
By: Kari E. Hacker, Shitanshu Uppal, and Carolyn Johnston
Pages: 1175–1182
Transdisciplinary Approach to Managing Hepatitis C Virus Infection in Patients at a Tertiary Care Cancer Center
By: Harrys A. Torres, Lillian R. Roach, Parag Mahale, Minas P. Economides, Boris Blechacz, Ethan Miller, Roy Borchardt, Anis Rashid, Thein H. Oo, Bhavarth Shukla, Malik Farida, Charles D. Ericsson, Bruno P. Granwehr, and Issam I. Raad
Pages: 1185–1188
  • Collapse
  • Expand